BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

47 related articles for article (PubMed ID: 14695793)

  • 1. The structure of Palau'amide, a potent cytotoxin from a species of the marine cyanobacterium Lyngbya.
    Williams PG; Yoshida WY; Quon MK; Moore RE; Paul VJ
    J Nat Prod; 2003 Dec; 66(12):1545-9. PubMed ID: 14695793
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Apratoxin H and apratoxin A sulfoxide from the Red Sea cyanobacterium Moorea producens.
    Thornburg CC; Cowley ES; Sikorska J; Shaala LA; Ishmael JE; Youssef DT; McPhail KL
    J Nat Prod; 2013 Sep; 76(9):1781-8. PubMed ID: 24016099
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Two New Neo-debromoaplysiatoxins-A Pair of Stereoisomers Exhibiting Potent Kv1.5 Ion Channel Inhibition Activities.
    Fan TT; Zhang HH; Tang YH; Zhang FZ; Han BN
    Mar Drugs; 2019 Nov; 17(12):. PubMed ID: 31766406
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biosynthetic origin of the 3-amino-2,5,7,8-tetrahydroxy-10-methylundecanoic acid moiety and absolute configuration of pahayokolides A and B.
    Liu L; Bearden DW; Rein KS
    J Nat Prod; 2011 Jun; 74(6):1535-8. PubMed ID: 21650153
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lyngbyaureidamides A and B, two anabaenopeptins from the cultured freshwater cyanobacterium Lyngbya sp. (SAG 36.91).
    Zi J; Lantvit DD; Swanson SM; Orjala J
    Phytochemistry; 2012 Feb; 74():173-7. PubMed ID: 22152977
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Absolute Structure Determination and Kv1.5 Ion Channel Inhibition Activities of New Debromoaplysiatoxin Analogues.
    Shen S; Wang W; Chen Z; Zhang H; Yang Y; Wang X; Fu P; Han B
    Mar Drugs; 2021 Nov; 19(11):. PubMed ID: 34822501
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Grassypeptolides F and G, cyanobacterial peptides from Lyngbya majuscula.
    Popplewell WL; Ratnayake R; Wilson JA; Beutler JA; Colburn NH; Henrich CJ; McMahon JB; McKee TC
    J Nat Prod; 2011 Aug; 74(8):1686-91. PubMed ID: 21806011
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tiglicamides A-C, cyclodepsipeptides from the marine cyanobacterium Lyngbya confervoides.
    Matthew S; Paul VJ; Luesch H
    Phytochemistry; 2009 Dec; 70(17-18):2058-63. PubMed ID: 19815244
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemical and Biological Study of Novel Aplysiatoxin Derivatives from the Marine Cyanobacterium
    Zhang HH; Zhang XK; Si RR; Shen SC; Liang TT; Fan TT; Chen W; Xu LH; Han BN
    Toxins (Basel); 2020 Nov; 12(11):. PubMed ID: 33238397
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enantioselective total synthesis of (+)-lyngbyabellin M.
    Pirovani RV; Brito GA; Barcelos RC; Pilli RA
    Mar Drugs; 2015 May; 13(6):3309-24. PubMed ID: 26023838
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Two new lyngbyatoxin derivatives from the Cyanobacterium, Moorea producens.
    Jiang W; Tan S; Hanaki Y; Irie K; Uchida H; Watanabe R; Suzuki T; Sakamoto B; Kamio M; Nagai H
    Mar Drugs; 2014 Dec; 12(12):5788-800. PubMed ID: 25470181
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Total synthesis of the marine cyanobacterial cyclodepsipeptide apratoxin A.
    Chen J; Forsyth CJ
    Proc Natl Acad Sci U S A; 2004 Aug; 101(33):12067-72. PubMed ID: 15231999
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Depsipeptides from a Guamanian Marine Cyanobacterium, Lyngbya bouillonii, with Selective Inhibition of Serine Proteases.
    Rubio BK; Parrish SM; Yoshida W; Schupp PJ; Schils T; Williams PG
    Tetrahedron Lett; 2010 Dec; 51(51):6718-6721. PubMed ID: 21103388
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rhizoleucinoside, a Rhamnolipid-Amino Alcohol Hybrid from the Rhizobial Symbiont Bradyrhizobium sp. BTAi1.
    Chen J; Sun J; Deering RW; DaSilva N; Seeram NP; Wang H; Rowley DC
    Org Lett; 2016 Mar; 18(6):1490-3. PubMed ID: 26959412
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Marine Cyanobacteria as Sources of Lead Anticancer Compounds: A Review of Families of Metabolites with Cytotoxic, Antiproliferative, and Antineoplastic Effects.
    Robles-Bañuelos B; Durán-Riveroll LM; Rangel-López E; Pérez-López HI; González-Maya L
    Molecules; 2022 Jul; 27(15):. PubMed ID: 35956762
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Determination of sequence and absolute configuration of peptide amino acids by HPLC-MS/CD-based detection of liberated N-terminus phenylthiohydantoin amino acids.
    Hahn D; Wang W; Choi H; Kang H
    Sci Rep; 2022 Jun; 12(1):10285. PubMed ID: 35717509
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Natural Cyclopeptides as Anticancer Agents in the Last 20 Years.
    Zhang JN; Xia YX; Zhang HJ
    Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33921480
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recent Advances in Small Peptides of Marine Origin in Cancer Therapy.
    Zhang QT; Liu ZD; Wang Z; Wang T; Wang N; Wang N; Zhang B; Zhao YF
    Mar Drugs; 2021 Feb; 19(2):. PubMed ID: 33669851
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Small-Scale Preparation of Fluorescently Labeled Chemical Probes from Marine Cyclic Peptides, Kapakahines A and F.
    Kamihira R; Nakao Y
    Mar Drugs; 2021 Jan; 19(2):. PubMed ID: 33572527
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and Biological Activities of Cyclodepsipeptides of Aurilide Family from Marine Origin.
    Michon S; Cavelier F; Salom-Roig XJ
    Mar Drugs; 2021 Jan; 19(2):. PubMed ID: 33498789
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.